相关实验视频

Updated: Jul 16, 2025

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

纤维细胞激活蛋白向PET/CT成像在未经治疗的前列腺癌患者中,具有低PSMA表达的患者

Xingyu Mu¹, Meng Li, Jingquan Huang

¹From the Department of Nuclear Medicine, Affiliated Hospitalof Guilin Medical University, Guilin, China.

Clinical nuclear medicine

|September 13, 2023

概括

18F-PSMA-1007 PET/CT在一个新的前列腺癌 (PCa) 病例中显示出最小的前列腺特异性膜抗原 (PSMA) 活性. 18F-FAPI-04 PET/CT揭示了更激烈的病变,这表明它有潜力评估具有低PSMA表达的PCa.

科学领域:

核医学是一种核医学.
在瘤学瘤学.
放射化学放射化学是指辐射化学.

背景情况:

前列腺特异性膜抗原 (PSMA) PET/CT越来越多地用于前列腺癌 (PCa) 的分期.
在某些患者中,PSMA的表达可能会有所不同,这可能会限制成像准确度.

更多相关视频

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

An Automated Radiosynthesis of [⁶⁸Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...